CSL 0.02% $295.21 csl limited

Will the CSL share price return to its all-time high?, page-29

  1. 5,952 Posts.
    lightbulb Created with Sketch. 281

    Buy these beaten down ASX 200 shares after the market selloff

    APXCSL

    red arrow pointing down and smashing through ground

    Image source: Getty Images

    Although today’s market selloff has been disappointing, every cloud has a silver lining.

    The silver lining on today’s selloff is that it has pulled down some quality ASX shares to attractive levels.

    Two beaten down ASX 200 shares that I would buy are listed below. Here’s why I think today’s selloff has created a buying opportunity:

    Appen Ltd (ASX: APX)

    The Appen share price ended the day 7% lower on Friday. This latest decline means that the shares of the leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI) markets are now down 25% from their 52-week high. And while this still means they trade at a premium of 37x estimated FY 2021 earnings, I believe this is great value given its very positive long term growth prospects.

    This is because spending on machine learning and AI is expected to grow materially over the next decade. I believe this puts Appen in a perfect position to grow its earnings at a strong rate during the 2020s. Overall, I feel this could make Appen shares market-beaters over the long term.

    CSL Limited (ASX: CSL)

    The CSL share price was out of form and tumbled 4% lower to $279.05 on Friday. As a result, the biopharmaceutical company’s shares are now trading approximately 19% below their 52-week high. I think this is a buying opportunity for investors that are looking for long term investment options.

    I believe CSL is one of the most outstanding shares on the Australian share market and capable of growing its earnings at a solid rate over the next decade. Especially given the quality of its therapies and vaccines, its growing plasma collection network, and its lucrative R&D pipeline. The latter has therapies under development which have the potential to generate billions of dollars in sales in the future if they make it to market.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*


 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
(20min delay)
Last
$295.21
Change
0.050(0.02%)
Mkt cap ! $142.6B
Open High Low Value Volume
$296.30 $298.20 $295.00 $229.6M 780.0K

Buyers (Bids)

No. Vol. Price($)
1 248 $295.20
 

Sellers (Offers)

Price($) Vol. No.
$295.21 42 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.